参考文献:1. Howlander N, Noone AM, Krapcho M, et al. / SEER Cancer Statistics Review, 1975鈥?010, National Cancer Institute. Bethesda, MD; Available at: http://seer.cancer.gov/csr/1975_2010/. Retrieved October 30, 2014. 2. Mohr, DN, Offord, KP, Owen, RA, Melton, LJ (1986) Asymptomatic microhematuria and urologic disease. A population-based study. JAMA. 256: pp. 224-229 CrossRef 3. Mariani, AJ, Mariani, MC, Macchioni, C, Stams, UK, Hariharan, A, Moriera, A (1989) The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis. J Urol. 141: pp. 350-355 4. Messing, EM, Young, TB, Hunt, VB, Wehbie, JM, Rust, P (1989) Urinary tract cancers found by homescreening with hematuria dipsticks in healthy men over 50聽years of age. Cancer 64: pp. 2361-2367 CrossRef 5. Sultana, SR, Goodman, CM, Byrne, DJ, Baxby, K (1996) Microscopic haematuria: urological investigation using a standard protocol. Br J Urol 78: pp. 691-696 CrossRef 6. Khadra, MH, Pickard, RS, Charlton, M, Powell, PH, Neal, DE (2000) A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice. J Urol. 163: pp. 524-527 CrossRef 7. Grossfeld, GD, Litwin, MS, Wolf, JS (2001) Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy-part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology 57: pp. 604-610 CrossRef 8. Davis, R, Jones, JS, Barocas, DA (2012) Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol 188: pp. 2473-2481 CrossRef 9. Buteau, A, Seideman, CA, Svatek, RS (2014) What is evaluation of hematuria by primary care physicians? Use of electronic medical records to assess practice patterns with intermediate follow-up. Urol Oncol 32: pp. 128-134 CrossRef 10. Friedlander DF, Resnick MJ, You C, et al. Variation in the Intensity of Hematuria Evaluation: A Target for Primary Care Quality Improvement. / Am J Med. Jan 28 2014. 11. Elias, K, Svatek, RS, Gupta, S, Ho, R, Lotan, Y (2010) High-risk patients with hematuria are not evaluated according to guideline recommendations. Cancer 116: pp. 2954-2959 CrossRef 12. Hollenbeck, BK, Dunn, RL, Ye, Z (2010) Delays in diagnosis and bladder cancer mortality. Cancer 116: pp. 5235-5242 CrossRef 13. Cohn, JA, Vekhter, B, Lyttle, C, Steinberg, GD, Large, MC (2014) Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: A nationwide claims-based investigation. Cancer 120: pp. 555-561 CrossRef 14. Klabunde, CN, Potosky, AL, Legler, JM, Warren, JL (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53: pp. 1258-1267 CrossRef 15. Krieger, N (1992) Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 82: pp. 703-710 CrossRef 16. Krieger, N, Williams, DR, Moss, NE (1997) Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Public Health. 18: pp. 341-378 CrossRef 17. Area Resurce File (ARF); National county-level Health Resource Information Database. 2012; Available at: http://ahrf.hrsa.gov/. Retrieved October 30, 2014. 18. Prout, GR, Wesley, MN, Greenberg, RS (2000) Bladder cancer: race differences in extent of disease at diagnosis. Cancer 89: pp. 1349-1358 CrossRef 19. Cardenas-Turanzas, M, Cooksley, C, Pettaway, CA, Sabichi, A, Grossman, HB, Elting, L (2006) Comparative outcomes of bladder cancer. Obstet Gynecol 108: pp. 169-175 CrossRef 20. Lee, CT, Dunn, RL, Williams, C, Underwood, W (2006) Racial disparity in bladder cancer: trends in tumor presentation at diagnosis. J Urol. Sep 176: pp. 927-933 CrossRef 21. Mallin, K, David, KA, Carroll, PR, Milowsky, MI, Nanus, DM (2011) Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007). J Urol. May 185: pp. 1631-1636 CrossRef 22. Mungan, NA, Aben, KK, Schoenberg, MP (2000) Gender differences in stage-adjusted bladder cancer survival. Urology 55: pp. 876-880 CrossRef 23. Scosyrev, E, Noyes, K, Feng, C, Messing, E (2009) Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer 115: pp. 68-74 CrossRef Coverage Matters: Insurance and Health Care. National Academies Press, Washington Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. National Academies Press, Washington 24. Prout, GR, Wesley, MN, McCarron, PG (2004) Survival experience of black patients and white patients with bladder carcinoma. Cancer 100: pp. 621-630 CrossRef 25. Bach, PB, Schrag, D, Brawley, OW, Galaznik, A, Yakren, S, Begg, CB (2002) Survival of blacks and whites after a cancer diagnosis. JAMA 287: pp. 2106-2113 CrossRef 26. Taub, DA, Hollenbeck, BK, Cooper, KL (2006) Racial disparities in resource utilization for cystectomy. Urology 67: pp. 288-293 CrossRef 27. Konety, BR, Allareddy, V, Carroll, PR (2007) Factors affecting outcomes after radical cystectomy in African Americans. Cancer 109: pp. 542-548 CrossRef 28. Barocas, DA, Alvarez, J, Koyama, T (2014) Racial variation in the quality of surgical care for bladder cancer. Cancer 120: pp. 1018-1025 CrossRef 29. Konety, BR, Joslyn, SA (2003) Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program. J Urol 170: pp. 1765-1771 CrossRef 30. Fedeli, U, Fedewa, SA, Ward, EM (2011) Treatment of muscle invasive bladder cancer: evidence from the National Cancer Database, 2003 to 2007. J Urol 185: pp. 72-78 CrossRef 31. Franks, P, Zwanziger, J, Mooney, C, Sorbero, M (1999) Variations in primary care physician referral rates. Health Serv Res 34: pp. 323-329 32. Franks, P, Williams, GC, Zwanziger, J, Mooney, C, Sorbero, M (2000) Why do physicians vary so widely in their referral rates?. J Gen Intern Med 15: pp. 163-168 CrossRef 33. Siegel, R, Naishadham, D, Jemal, A (2012) Cancer statistics, 2012. CA Cancer J Clin 62: pp. 10-29 CrossRef 34. Johnson, EK, Daignault, S, Zhang, Y, Lee, CT (2008) Patterns of hematuria referral to urologists: does a gender disparity exist?. Urology 72: pp. 498-502 CrossRef 35. Lyratzopoulos G, Abel GA, McPhail S, Neal RD, Rubin GP. Gender inequalities in the promptness of diagnosis of bladder and renal cancer after symptomatic presentation: evidence from secondary analysis of an English primary care audit survey. / BMJ Open. 2013;3(6). 36. Miller, DC, Murtagh, DS, Suh, RS (2011) Regional collaboration to improve radiographic staging practices among men with early stage prostate cancer. J Urol 186: pp. 844-849 CrossRef 37. Burks, FN, Liu, AB, Suh, RS (2012) Understanding the use of immediate intravesical chemotherapy for patients with bladder cancer. J Urol 188: pp. 2108-2113 CrossRef 38. Barocas, DA, Liu, A, Burks, FN (2013) Practice based collaboration to improve the use of immediate intravesical therapy after resection of nonmuscle invasive bladder cancer. J Urol 190: pp. 2011-2016 CrossRef 39. Loo, RK, Lieberman, SF, Slezak, JM (2013) Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria. Mayo Clin Proc 88: pp. 129-138 CrossRef 40. Lillie-Blanton, M, Brodie, M, Rowland, D, Altman, D, McIntosh, M (2000) Race, ethnicity, and the health care system: public perceptions and experiences. Med Care Res Rev. 57: pp. 218-235 CrossRef 41. Burgess, DJ, Fu, SS, Ryn, M (2004) Why do providers contribute to disparities and what can be done about it?. J Gen Intern Med 19: pp. 1154-1159 CrossRef